Home
About
Our Work
Success Stories
Insights
Contact
OUR WORK
Explore recent placements
Unmatched talent to bring you an unmatched advantage.
All Posts
Board
CEO
CFO
Comms/IR
COO
CDO/CTO
CSO
CMO
CBO
CPO
CLO
CRO
TechBio
CCO
CCO
Occam Recruits Chief Commercial Officer at Geron
9.10.24
CFO
Occam Places CFO for Prominent Swiss Biotech Alentis
8.13.24
Board
Occam’s Board Practice Continues to Flourish
7.22.24
CEO
TechBio
Occam’s European TechBio Practice Accelerates with the Recruitment of Nucleome CEO Mark Bodmer, PhD
7.16.24
CEO
Occam Recruits CEO for Khosla, GV, and Third Rock Investment EveryONE Medicines
7.10.24
CDO/CTO
TechBio
Occam Places Radu Dobrin as CTO of Deep Genomics
6.13.24
CPO
Occam Recruits Human Capital Partner for Prominent Healthcare PE/VC Investor
6.7.24
CEO
Occam Places Jim Burns as CEO of Ensoma
5.13.24
CMO
Occam Places Chief Development Officer of Groundbreaking Longevity Player, Loyal
5.1.24
CEO
Occam Recruits Brent Warner as CEO for Protego Biopharma
4.16.24
Board
Occam Enhances CytomX's Board with Experienced Physician Executive
3.21.24
CSO
Occam Places CSO of ADC Biotech MBrace Therapeutics
3.6.24
CDO/CTO
TechBio
Occam Places Adrian Schreyer as CTO of Anagenex
3.4.24
CSO
Occam Recruits Translational Leader for Gene Editing Leader Mammoth
2.27.24
CSO
Occam Recruits CSO for Public Gene Therapy Company, Adverum
2.2.24
Board
Occam Places Biotech Leader David Southwell as Chairman of Revolo Biotherapeutics
1.25.24
CBO
TechBio
Occam Recruits CBO for Parisian Generative AI Drug Discovery Platform Company, Iktos
1.18.24
CEO
Occam Recruits Sanjeev Luther as President and CEO of Eterna Therapeutics
12.22.23
Board
TechBio
Occam's AI Practice Expands with the Recruitment of Dr. Rajiv Patni as Strategic Clinical Advisor to BioXcel Therapeutics
12.15.23
CSO
TechBio
Occam’s UK Biotech Practice Accelerates with Placement of CSO at Nucleome
11.13.23
CEO
Occam Recruits CEO of Prominent Rare Disease Research Foundation
11.9.23
CMO
Occam Continues to Serve the Gene Therapy/Gene Editing Space, Recruiting Wes Miller as CMO of Epic Bio
10.24.23
CDO/CTO
TechBio
Occam Places Senior DeepMind Leader as VP of AI/ML at GSK
10.16.23
CSO
TechBio
Occam Places Manju Ramarao as CSO of Atomic AI
10.12.23
CSO
Occam Places Nick Pullen as CSO of ARTBIO
10.5.23
CFO
Key Financial Executive Placement Expands Global Tech Practice
9.28.23
CLO
Occam Places General Counsel for Public Biopharma KalVista Pharmaceuticals
9.21.23
CFO
Occam Recruits Michelle Robertson as CFO of Geron Corporation
9.15.23
CLO
Occam Places Chief Legal Officer at Public Oncology Biotech
8.12.23
CEO
TechBio
Occam Places Bryan Stuart as CEO of Atavistik
7.20.23
CSO
Occam Places Kimberly Scearce-Levie as Chief Development Officer of Cajal Neuroscience
7.17.23
CRO
Occam's Tech Practice Places CRO at Engageli, a Collaborative SW Developer
7.10.23
Board
Occam Places Mark Strobeck on the Board of Windtree
7.4.23
CEO
Occam Places CEO for RadioPharm Start-Up
6.27.23
CBO
TechBio
Occam’s UK Practice Expands, Placing Swati Chatterjee as SVP Sales & Business Development of Chemify
6.15.23
CSO
Occam Recruits David Moller as Chief Scientific Officer of Variant Bio
6.6.23
CFO
Occam Places Brian Piekos as CFO of Elicio Therapeutics
6.2.23
CMO
TechBio
Occam Places R&D Leader David Mauro as CMO at Recursion
5.16.23
COO
CDO/CTO
TechBio
Occam’s Global Tech Practice Continues to Expand, Placing Daniel Delubac as COO & CTO at Chemify
5.3.23
Board
TechBio
Occam Places Andrew Allen as Board Chair of Peptone
4.24.23
Load More
No Results Found!
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
